It is noteworthy that Purinergic receptors are abundantly expressed in urological cancers, including KIRC, and that ATP can influence tumor-associated signaling pathways through the Purinergic receptor P2RX6, further promoting the migration and invasion of renal tumors [12, 13]. The gene discussed is P2RY2; the disease is neoplasm.